This Membership Interest Purchase Agreement (this “Agreement”), dated as of October 6, 2026, by and among Hepion Pharmaceuticals, Inc., a Delaware corporation (the “Buyer”), Gravitas Life Sciences, LLC, a Delaware limited liability compa...
HEPION PHARMACEUTICALS, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify as follows:
We have read the statements made by Hepion Pharmaceuticals, Inc. under Item 4.01 of its Form 8-K dated September 24, 2026, and we agree with the statements concerning our Firm in such Form 8-K. We have no basis to agree or disagree with ...
THIS CONVERTIBLE NOTE PURCHASE AGREEMENT (the “Agreement”) is made as of September 3, 2026, by and between Hepion Pharmaceuticals, Inc., a Delaware corporation (and together with all of its current and future, direct and/or indirect, who...
